LSV Associates II, LLC is 10% Owner at ALX ONCOLOGY HOLDINGS INC (ALXO). They have made 1 open-market trade across 1 company since 2021, most recently 2021-12-10.
CIK 0001818388
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXO | 2,232,251 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2021-12-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXO | SELL | 2021-12-08 | 2021-12-10 | $32.26 | $4.7M | -26.4% | -34.8% | -38.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.